Overview of Dr. Jelinek
Dr. Michael Jelinek is an oncologist in Chicago, IL and is affiliated with multiple hospitals in the area, including Rush University Medical Center and Rush Oak Park Hospital. He received his medical degree from Rush Medical College and completed his residency and fellowship and University of Chicago. He specializes in head & neck cancer and thoracic cancer.
Office
1725 W. Harrison St
Suite 809
Chicago, IL 60612
Education & Training
University of ChicagoFellowship, Hematology and Medical Oncology, 2016 - 2019- University of ChicagoResidency, Internal Medicine, 2013 - 2016
Rush Medical College of Rush University Medical CenterClass of 2013
Certifications & Licensure
IL State Medical License 2013 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Study of EP0031 in Patients With Advanced RET-altered Malignancies Start of enrollment: 2022 Sep 30
Roles: Contact
Publications & Presentations
PubMed
- 7 citationsCurrent State and Future Directions of EGFR-Directed Therapy in Head and Neck Cancer.Praveena Tathineni, Nikhil Joshi, Michael J Jelinek
Current Treatment Options in Oncology. 2023-06-01 - 8 citationsPredicting Acute Renal Injury in Cancer Patients Receiving Cisplatin Using Urinary Neutrophil Gelatinase-Associated Lipocalin and Cystatin CMichael J. Jelinek, Sang Mee Lee, Alicia Wyche Okpareke, Claudia Wing, Jay L. Koyner
Clinical and Translational Science. 2018-07-01 - 42 citationsA Phase I Trial of Concurrent Or Sequential Ipilimumab, Nivolumab, and Stereotactic Body Radiotherapy in Patients with Stage IV Non-Small Cell Lung Cancer (COSINR Study)Christine M. Bestvina, K.B. Pointer, Theodore Karrison, Hania A. Al-Hallaq, Philip C. Hoffman
Journal of Thoracic Oncology. 2021-09-06
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
